1. Germany Stocks

  2. •

    Technology services

  3. •

    Packaged software
MeVis Medical Solutions AG

MeVis Medical Solutions AG

20.80
EUR
0.00
(0.00%)
50.23MMarket Cap
MeVis Medical Solutions AG
DUS:M3V
(Dusseldorf Stock Exchange)

Recent

price

20.80

P/E

ratio

- -

div

yld

- -

ROIC.AI

2009
2010
2011
2012
2013
2014
2015
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
EUR
8.16
8.37
7.95
7.75
7.42
7.6
8.94
10.19
9.77
9.93
9.41
8.91
10.31
9.53
9.33
8.82
- -
Revenue per Share
0.23
-4.89
-2.38
1.26
2.14
2.16
3.76
3.09
4.19
4.43
3.13
2.5
4.28
2.7
2.51
1.74
- -
Basic EPS, GAAP
0.02
1.04
2.74
2.96
4.23
2.59
3.61
3.9
2.71
3.48
1.53
4.99
2.6
3.17
1.56
2.05
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
0.04
- -
5.15
0.89
0.86
3.13
2.5
4.28
2.7
2.51
- -
Dividend per Share
19.21
14.45
12.05
12.51
15.35
17.57
18.53
17.86
9.79
9.79
9.79
9.79
9.79
9.79
9.79
9.79
9.79
Book Value per Share
3.25
1.62
1.05
3.89
6.26
8.5
10.92
11.42
9.74
9.78
9.79
9.79
9.79
9.79
9.79
9.79
9.79
Tangible Book Value per Share
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
Basic Weighted Avg Shares
14
14
14
13
13
13
16
19
18
18
17
16
19
17
17
16
- -
Sales/Revenue/Turnover
11.77
-37.97
7.82
22.56
34.42
30.02
30.06
43.32
40.56
39.51
36.02
31
34.49
28.28
23.58
14.58
- -
Operating Margin (%)
3
9
6
3
2
2
2
1
- -
- -
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
- -
-8
-4
2
4
4
7
6
8
8
6
5
8
5
5
3
- -
Net Income, GAAP
65.92
- -
- -
8.27
6.76
24.9
- -
21.57
1.15
1.04
1.56
1.84
1.11
2.27
2.7
3.45
- -
Effective Tax Rate (%)
2.87
-58.42
-29.92
16.21
28.8
28.36
42.06
30.32
42.86
44.66
33.3
28.04
41.52
28.37
26.87
19.71
- -
Profit Margin (%)
10
6
5
7
11
15
17
17
4
4
4
4
5
5
3
3
3
Working Capital
7
- -
1
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
LT Debt
33
25
21
23
26
30
34
33
18
18
18
18
18
18
18
18
18
Total Equity
1.26
- -
- -
11.06
15.59
9.93
- -
15.14
21.1
37.64
32.22
24.18
35.66
26.68
21.68
12.6
- -
Return on Invested Capital (%)
1.72
- -
- -
10.48
15.24
13.19
- -
14.14
24.9
43.36
32.06
25.56
43.72
27.83
25.69
17.76
- -
Return on Capital (%)
1.22
-29.09
-17.98
9.95
14.96
13.09
21.05
16.97
30.27
45.28
32
25.5
43.69
27.6
25.59
17.76
- -
Return on Common Equity (%)

Capital Structure

EUR

•

in mil. unless spec.
Jun'19
Sep'19
Mar'20
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
2
2
2
Market Capitalization
52
52
50

Working Capital

EUR

•

in mil. unless spec.
Jun'19
Sep'19
Mar'20
Total Current Assets
10
7
8
Cash, Cash Equivalents & STI
3
3
3
Accounts Receivable, Net
3
2
2
Inventories
- -
- -
- -
Total Current Liabilities
4
4
5
Payables & Accruals
- -
- -
- -
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

EUR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
- -
Free Cash Flow
17.74%
36.15%
31.44%
Net Income, GAAP
5.33%
-4.73%
-30.58%
Sales/Revenue/Turnover
2.57%
-0.94%
-5.37%
Total Cash Common Dividend
- -
54%
-7.29%

Semi-annual Revenue

EUR

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
17
2025
- -
- -
16
2026
- -
- -
- -

Semi-annual Earnings Per Share

EUR

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
2.51
2025
- -
- -
1.74
2026
- -
- -
- -

Semi-annual Dividends Per Share

EUR

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
2.7
2025
- -
- -
2.51
2026
- -
- -
- -
Similar Companies
Microsoft Corporation (NASDAQ:MSFT)
Palantir Technologies Inc. (NASDAQ:PLTR)
Nebius Group N.V. (NASDAQ:NBIS)
Oracle Corporation (NYSE:ORCL)
CoreWeave, Inc. (NASDAQ:CRWV)
ServiceNow, Inc. (NYSE:NOW)
Business
MeVis Medical Solutions AG (M3V.DE) develops and markets software solutions for medical imaging analysis and visualization, primarily focused on diagnostic support in radiology and oncology. The company offers advanced image processing tools including MeVisLab, a modular platform for creating customized medical image processing applications; Riverain Medical's ClearRead Detect and ClearRead Compare for chest CT and X-ray analysis to aid in lung nodule and lesion detection; Fraunhofer MEVIS research software for liver and lung applications; and services such as customized software development, regulatory validation, and clinical workflow integration. These products serve healthcare providers, medical device manufacturers, and research institutions worldwide, with operations spanning Europe, North America, and Asia; MeVis Medical Solutions AG was founded in 1995 and is headquartered in Bremen, Germany, as a subsidiary of Fraunhofer-Gesellschaft. In recent developments, the company completed the acquisition of Riverain Medical in 2023, expanding its AI-powered chest imaging portfolio with FDA-cleared technologies for early lung disease detection, followed by CE marking approvals in Europe for ClearRead products in 2024. MeVis continues to advance its oncology-focused software through partnerships with leading radiology systems providers and participation in Fraunhofer research initiatives on multimodal imaging. No major funding rounds, name changes, or operational reorganizations have been reported in the last two years, with strategic emphasis on integrating acquired technologies into global sales channels and enhancing AI capabilities for precision diagnostics.